Dr Mathias Wipf is working as a guest scientist at the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) in Muttenz. He is developing novel in vitro diagnostics technologies for rapid and point-of-care testing. Dr Wipf is a co-founder and CEO of MOMM Diagnostics, a start-up company developing rapid tests for preeclampsia, a dangerous pregnancy condition.

Dr Wipf’s background is in nanoscience and physics with a focus on biosensor technologies. He is an innovation-driven scientist and entrepreneur with a strong interest in novel sensor concepts for healthcare and the biomedical industry, striving to understand fundamental processes and to implement technologies to improve quality of life.